Showing 3601-3610 of 23204 results for "".
AFib: Clinical and Academic Updates
https://reachmd.com/programs/clinicians-roundtable/afib-clinical-and-academic-updates/448/Dr. Bradley Knight will discuss approaches to controlling the heart rate and preventing thromboembolic complications in patients with atrial fibrillation.Acute Decompensated Heart Failure:the UNLOAD Trial
https://reachmd.com/programs/clinicians-roundtable/acute-decompensated-heart-failurethe-unload-trial/137/Dr. Anderson reviews the UNLOAD Trial and its findings.The Proliferation of Food Allegies
https://reachmd.com/programs/clinicians-roundtable/the-proliferation-of-food-allegies/74/Dr. Clifford Bassett, Allergist and Assistant Clinical Professor of Medicine and Otolaryngology at Long Island College Hospital in New York speaks about the "why" behind food allergies and cultural factors affecting the field.Autism: Treatment Strategies
https://reachmd.com/programs/clinicians-roundtable/autism-treatment-strategies/45/Dr. Schreibman discusses the pharmacologic and non-drug treatment options for achieving the best results with the autistic patient.Coronary Artery Disease
https://reachmd.com/programs/clinicians-roundtable/coronary-artery-disease/3/Dr. Philip Faraci discusses disease origin and current medical treatment options for CAD and Aortic Valve DiseaseUnderstanding the Cardiovascular Risks of ADHD Medications
https://reachmd.com/programs/neurofrontiers/understanding-the-cardiovascular-risks-of-adhd-medications/24315/Prolonged use of stimulant medications may be linked to cardiovascular risks. Here’s how we can prevent these risks in patients with ADHD.Post-Hoc Analysis of Scalp Psoriasis Treatment After Five Years
https://reachmd.com/programs/clinicians-roundtable/post-hoc-analysis-of-scalp-psoriasis-treatment-after-five-years/24371/Scalp psoriasis can be a particularly challenging manifestation for many patients. Tune in to learn more.The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
https://reachmd.com/programs/cme/the-safety-equation-managing-adverse-events-associated-with-csf1r-inhibitors-in-tgct/48910/Explore TGCT recognition, clinical evidence, treatment strategies, and management of adverse events with CSF1R inhibitors in an interdisciplinary context.Promising Therapies on the Atopic Dermatitis Horizon
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37178/Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, previews important potential developments in the atopic dermatitis pipelineUnderstanding ADHD: Epidemiology, Impacts, and Management
https://reachmd.com/programs/neurofrontiers/understanding-adhd-epidemiology-impacts-and-management/18153/Here’s what we currently know about the epidemiology, impacts, and management of ADHD.